BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33919909)

  • 1. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases-Markers Involved in the Regulation of Apoptosis-In Patients with Ovarian Cancer.
    Mielczarek-Palacz A; Jasińska S; Strzelec A
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 - markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics.
    Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z
    Arch Med Sci; 2017 Apr; 13(3):624-628. PubMed ID: 28507579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer-Participation in Pathogenesis or a Possible Clinical Use?
    Mielczarek-Palacz A; Kondera-Anasz Z; Smycz-Kubańska M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration of soluble ligand for receptor CD30 (sCD30L)--marker of apoptosis in women with ovarian tumor].
    Mielczarek-Palacz A; Kondera-Anasz Z; Sikora J; Sodowski K; Switała J; Kubina R
    Ginekol Pol; 2009 Jul; 80(7):494-7. PubMed ID: 19697811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune complex p53 protein/anti-p53 autoantibodies in the pathogenesis of ovarian serous carcinoma.
    Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Smycz-Kubańska M; Englisz A; Strzelczyk J; Kabut J
    Ginekol Pol; 2020; 91(9):519-253. PubMed ID: 33030731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance in serum soluble CD30/CD30L and CD40/CD40L systems are associated with ovarian tumors.
    Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Hauza G
    Hum Immunol; 2013 Jan; 74(1):70-4. PubMed ID: 23073297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single CpG island methylation is not sufficient to maintain the silenced expression of CASPASE-8 apoptosis-related gene among women with epithelial ovarian cancer.
    Braga Lda C; Silva LM; Ramos AP; Piedade JB; Vidigal PV; Traiman P; da Silva Filho AL
    Biomed Pharmacother; 2014 Feb; 68(1):87-91. PubMed ID: 24412083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin expression at the mRNA level in tumors and the protein concentration in the serum and peritoneal fluid in patients with serous ovarian tumors.
    Kruszniewska-Rajs C; Smycz-Kubanska M; Strzalka-Mrozik B; Strzelczyk J; Szanecki W; Witek A; Gola J; Mielczarek-Palacz A
    Ginekol Pol; 2023; 94(6):435-441. PubMed ID: 36929784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of microsatellite instability in women with epithelial ovarian cancer.
    Caliman LP; Tavares RL; Piedade JB; DE Assis AC; DE Jesus Dias DA Cunha K; Braga LD; Silva LM; DA Silva Filho AL
    Oncol Lett; 2012 Sep; 4(3):556-560. PubMed ID: 22970055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid and lymphoid dendritic cells in the peritoneal fluid of women with ovarian cancer.
    Wertel F; Polak G; Roliński J; Barczyński B; Kotarski J
    Adv Med Sci; 2006; 51():174-7. PubMed ID: 17357302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis.
    Feng Q; Li P; Salamanca C; Huntsman D; Leung PC; Auersperg N
    Cancer Res; 2005 Oct; 65(19):8591-6. PubMed ID: 16204022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer.
    Cobellis L; Reis FM; Luisi S; Danero S; Pirtoli L; Scambia G; Petraglia F
    J Soc Gynecol Investig; 2004 May; 11(4):203-6. PubMed ID: 15120692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cance.
    Smycz-Kubańska M; Stępień S; Gola JM; Kruszniewska-Rajs C; Wendlocha D; Królewska-Daszczyńska P; Strzelec A; Strzelczyk J; Szanecki W; Witek A; Mielczarek-Palacz A
    Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35920183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer.
    Englisz A; Smycz-Kubańska M; Mielczarek-Palacz A
    Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of some tumor markers in differential diagnosis of ovarian tumor.
    Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
    Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer.
    Chen C; Ge J; Lu Q; Ping G; Yang C; Fang X
    J Ovarian Res; 2015 May; 8():28. PubMed ID: 25956476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of prognostic factors for the extent of vascularity of serous ovarian cancer on the basis of CD34 antigen expression].
    Blok R; Blok K; Jeleń M; Gryboś M
    Ginekol Pol; 2004 Feb; 75(2):91-8. PubMed ID: 15108579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.